BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
43 hedge funds and large institutions have $8.85M invested in BRAINSTORM CELL THERAPUTC in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.02% less ownership
Funds ownership: 0.63% → 0.61% (-0.02%)
82% less call options, than puts
Call options by funds: $244K | Put options by funds: $1.38M
Holders
43
Holding in Top 10
–
Calls
$244K
Puts
$1.38M
Top Buyers
| 1 | +$157K | |
| 2 | +$149K | |
| 3 | +$133K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$52K |
| 5 |
CG
CFO4Life Group
Coppell,
Texas
|
+$51K |
Top Sellers
| 1 | -$349K | |
| 2 | -$141K | |
| 3 | -$104K | |
| 4 |
WG
Winton Group
London,
United Kingdom
|
-$51.1K |
| 5 |
VF
Virtu Financial
New York
|
-$51K |